LAMA2 conference
Getting Closer to a Treatment for LAMA2-RD
Patients, clinicians, and scientists united
The conference
After successful conferences in Maastricht (2019) and Barcelona (2023), we are pleased to announce the third LAMA2-RD-focused meeting, to be held in Istanbul, Türkiye, from March 27–29, 2026. The event will bring together clinicians, researchers, patient organizations, patients, and families to share progress in understanding and treating LAMA2-MD
While patients have been involved in previous meetings, their participation will now be a strong focus. LAMA2-MD is a rare condition and most patients, or their families never meet others with the same condition, and clinicians may see only one or two cases in their careers. This will offer a unique opportunity for patients, families, and experts to connect, share experiences, and learn from one another.
To learn more, navigate the website using the hyperlinks in the header of the page
LAMA2 muscular dystrophy
LAMA2-related muscular dystrophy (LAMA2-RD) is an inherited muscle disease which manifests with muscle weakness and reduced muscle tension, often present since birth. This is because of the absence of, or a defect in the structure of a protein that anchors the muscle to the surrounding tissue. Although the condition is inherited, the parents of a child with LAMA2-RD do not usually have any symptoms, as for it to occur, 2 copies of a mutated gene are needed, each inherited from a single parent.
“I am perfect the way I am, even though I have a muscle disease.”
-Hicham Amirouch (29)
Location
Türkiye has a large and active LAMA2 community and its clinicians were involved in identifying the first defects in the LAMA2 gene. Hosting the meeting in Istanbul will contribute to the global
LAMA2 network by providing new insights and opportunities for collaboration.